Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Laura K. Whited"'
Autor:
Laura K. Whited, Jose Banchs, Richard E. Champlin, Uday R. Popat, Elizabeth J. Shpall, Gabriela Rondon, Rima M. Saliba, Jason Yeh
Publikováno v:
Blood Advances
Key Points The incidence of acute cardiac toxicity remains low and manageable after matched allo-HCT in the era of PTCy prophylaxis.Older age, hypertension, arrhythmia, diabetes, and cardiac comorbidities increase this risk of cardiac toxicity but PT
Publikováno v:
Future Microbiology. 15:389-400
Brincidofovir (BCV) is a lipid conjugate of cidofovir with good oral bioavailability, enabling optimal intracellular levels of the active drug. Lower rates of nephrotoxicity and myelotoxicity make it a favorable alternative. Despite a greater safety
Autor:
Lihui Cao, Joyce Neumann, Laura K. Whited, Haley E. Gale-Capps, Terri Lynn Shigle, Uday R. Popat, Rachel Ombres, An Ngo-Huang, Tacara Soones, Zandra R. Rivera, Hilary Barelas Sullivan, Rhodora C. Fontillas, Brent Braveman, Brittany C. Kurse, Jill K. Ferguson, David Marin, Richard Lindsay, Nicholas A. Szewczyk, Alison M. Gulbis, Elizabeth J. Shpall, Whitney Wallis, Richard E. Champlin, Latoya Adekoya
Publikováno v:
Transplantation and cellular therapy. 27(12)
Increasingly, patients age ≥65 years are undergoing allogeneic hematopoietic stem cell transplantation (allo-SCT). Although age alone is a well-documented predictor of overall survival (OS) and nonrelapse mortality (NRM), growing evidence suggests
Publikováno v:
PharmacotherapyReferences. 40(8)
Allogeneic hematopoietic cell transplantation (HCT) remains the only curable option for adult patients with hematologic malignancies. According to guidelines published by the American Society for Transplantation and Cellular Therapy, allogeneic HCT s
Autor:
Laura K. Whited, Jacinth Joseph, Gheath Alatrash, Megan Cornelison-Marcotulli, Rohtesh S. Mehta, Marina Konopleva, Gabriela Rondon, Ala Abudayyeh, Chantal Saberian, Guillermo Garcia-Manero, Naval Daver, Amin M. Alousi, Hind Rafei, Uday R. Popat, Cristina Knape, Richard E. Champlin, Noha Abdel-Wahab, May Daher, Maro Ohanian, Adi Diab, Farhad Ravandi, Stephen K. Gruschkus, Betul Oran, Alison M. Gulbis
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S201-S202
Context There are concerns that the use of immune checkpoint inhibitors (ICIs) after allogeneic stem cell transplant (allo-SCT) may increase the incidence of acute graft-versus-host disease (aGVHD). Objective We report our experience with ICIs used a
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S393-S394
Introduction PTCy-based GVHD prophylaxis has emerged as an effective method in Allo-HCT. Cyclophosphamide has historically been associated with increased rates of cardiac toxicities. This potential complication plays a role in the choice of optimal G
Autor:
Zandra R. Rivera, Latoya Adekoya, Uday R. Popat, Courtland A. Lee, Richard E. Champlin, Hillary Barelas Sullivan, Laura K. Whited, Becky McMullin, Jill Ferguson, Julianne Chen, Richard Lindsay, Gabriela Rondon, Lihui Cao, Alison M. Gulbis, Rima M. Saliba, Terri Lynn Shigle, Nicholas A. Szewczyk, Rhodora C. Fontillas, Haley Gale, Tacara Soones, An Ngo-Huang
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S49-S50
Background Older patients undergoing allogeneic stem cell transplant (SCT) have inferior outcomes. They have limited physiological reserves, which makes them more susceptible to toxic effects of conditioning regimens. Supportive care directed at main
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 76(Supplement_4)
Purpose Intravenous immune globulin (IVIG) is a high-cost medication used in a diverse range of settings. At many institutions, IVIG is dosed using total body weight (TBW). Recent evidence suggests that alternative dosing weights reduce waste without
Autor:
Gheath Alatrash, Farhad Ravandi, Rohtesh S. Mehta, Stephen K. Gruschkus, Betul Oran, May Daher, Cristina Knape, Chantal Saberian, Ala Abudayyeh, Guillermo Garcia-Manero, Richard E. Champlin, Amin M. Alousi, Megan Marcotulli, Noha Abdel-Wahab, Laura K. Whited, Jacinth Joseph, Gabriela Rondon, Hind Rafei, Alison M. Gulbis, Maro Ohanian, Adi Diab, Uday R. Popat, Marina Konopleva, Naval Daver
Publikováno v:
Blood. 136:1-1
Background: Allogeneic hematopoietic stem cell transplantation (alloHCT) remains a curative approach for patients with AML/MDS. Still, up to 50 % of patients relapse after alloHCT. Immune checkpoint inhibitors (ICI) are being used in the post-transpl
Autor:
Dusten T. Rose, Christopher Lowe, Dawn Moore, Marc H. Scheetz, Kelli Thoele, Laura K. Whited, Patrick J. Kiel, Nathaniel J. Rhodes, J. Nicholas O'Donnell, Jessica Neeb, Meagan Grove, David R. Jones
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 36:1003-1010
tudy Objective To evaluate the steady-state pharmacokinetic parameters of standard cefepime dosing regimens in a hematologic malignancy and hematopoietic cell transplant patient population with febrile neutropenia. Design Open-label, single-center, p